Tj Biopharma Co., Ltd.

This study is testing whether adding a new drug called uliledlimab to standard immunotherapy and chemotherapy works better for advanced lung cancer patients who haven't had prior treatment. About 150 patients with stage IIIB-IV non-small cell lung cancer will receive either the n…

This study is testing whether adding a new drug called uliledlimab to an existing immunotherapy (toripalimab) works better than standard single-drug immunotherapies for advanced non-small cell lung cancer. It will enroll 450 adults with previously untreated cancer that has spread…